Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
110 hedge funds and large institutions have $136M invested in Ventyx Biosciences in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 39 reducing their positions, and 23 closing their positions.
253% more call options, than puts
Call options by funds: $522K | Put options by funds: $148K
43% more capital invested
Capital invested by funds: $95.1M → $136M (+$41.3M)
0.94% less ownership
Funds ownership: 62.43% → 61.5% (-0.94%)
4% less funds holding
Funds holding: 114 → 110 (-4)
17% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 23
21% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 39
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$2.71M |
| 2 |
6CM
683 Capital Management
New York
|
+$2.65M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.61M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.26M |
| 5 |
Two Sigma Investments
New York
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.11M |
| 2 |
AAA
Affinity Asset Advisors
New York
|
-$1.62M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.45M |
| 4 |
MAM
Monaco Asset Management
Monaco
|
-$1.42M |
| 5 |
SCM
Sio Capital Management
New York
|
-$1.27M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EGM
126
Engineers Gate Manager
New York
| – | -$41.8K | -19,517 | Closed |
|
|
PCA
127
Pallas Capital Advisors
Braintree,
Massachusetts
| – | -$38.1K | -17,824 | Closed |
|
128
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$33.9K | -15,864 | Closed |
|
|
DS
129
DRW Securities
Chicago,
Illinois
| – | -$33.5K | -15,637 | Closed |
|
130
Mariner
Overland Park,
Kansas
| – | -$26.7K | -12,468 | Closed |
|
131
Neuberger Berman Group
New York
| – | -$24.1K | -11,261 | Closed |
|
132
Focus Partners Wealth
Boston,
Massachusetts
| – | -$21.6K | -10,086 | Closed |
|
133
Raymond James Financial
St Petersburg,
Florida
| – | -$9.51K | -4,444 | Closed |
|
VTYX Hedge Fund Activity: Q3 2025 in Review
110 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q3 2025, worth a combined $136M — up 43% from $95.1M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of VTYX and 19 opened new positions — a net loss of 4 holders — while 39 trimmed existing stakes and 31 added.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $2.71M. The largest seller was Point72 Asset Management, cutting an estimated $7.11M.
- 110 institutional investors held Ventyx Biosciences (VTYX) as of Q3 2025, down from 114 in Q2 2025.
- Funds reported $136M of Ventyx Biosciences stock for Q3 2025, up 43% quarter-over-quarter.
- 19 funds opened new Ventyx Biosciences positions in Q3 2025 and 23 closed out, a net change of -4 holders.
- The largest Ventyx Biosciences buyer in Q3 2025 was Baker Bros. Advisors, an estimated $2.71M added.
- The largest Ventyx Biosciences seller in Q3 2025 was Point72 Asset Management, an estimated $7.11M sold.
Based on aggregated 13F filings for Q3 2025.